Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Ceskoslovenska Patologie|August 1, 1997
[N-myc oncogene amplification in tumors of the sympathetic nervous system: preliminary study of methods and clinico-pathologic correlations]R Dahbiová, R Kodet, J Soukup, et al.Pathology, Research and Practice|August 1, 1996
Congenital-infantile fibrosarcoma: a clinicopathological study of five patients entered on the Prague children's tumor registryR Kodet, J Stejskal, D Pilát, et al.Casopis Lekaru Ceskych|June 22, 1999
Treatment of children and adolescents with non-Hodgkin's lymphoma (results based on the NHL Berlin-Frankfurt-Münster 90 protocols)P Kavan, E Kabicková, P Gajdos, et al.Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|February 1, 1994
[Surgical methods in the treatment of retroperitoneal neuroblastoma]J Snajdauf, L Zeman, M Horn, et al.Ceskoslovenska Pediatrie|August 1, 1990
[Long-term catheterization of the central venous system in children]J Spatenka, V Smelhaus, V Spicáková, et al.Casopis Lekaru Ceskych|December 13, 2005
[Treatment results of Langerhans cell histiocytosis with LSH II protocol]H Mottl, M Ganevová, J Radvanská, et al.Pediatric Pathology|May 1, 1994
Epithelioid sarcoma in childhood: An immunohistochemical, electron microscopic, and clinicopathologic study of 11 cases under 15 years of age and review of the literatureR Kodet, V Smelhaus, W A Newton, et al.Casopis Lekaru Ceskych|February 24, 2001
[Detection of minimal residual disease in Ewing's sarcoma using RT-PCR]A Vícha, D Sumerauer, T Eckschlager, et al.Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 16, 2009
[Clinical relevance of chromosomal aberrations in bone and soft tissue tumors in children and young adults]E Stejskalová, M Jarosová, J Malis, et al.Pediatric Hematology and Oncology|September 16, 2000
A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapyL White, S A Daly, C J McKenna, et al.Pageof 3